BACKGROUND:Urine samples constitute a major proportion of the samples tested in routine diagnostic laboratories. Nitrofurination used to treat urinary tract infection (UTI) for both Gram-positive and negative bacteria. Resistance to UTI is growing with time, so continuous evaluation of antibiotic is urgent.MATERIALS AND METHODS:Mid-stream urine samples were collected from patients suspected with UTI. All these samples were inoculated on culture media aerobically at 37°C for overnight. A total of 100 bacteria of bothEscherichia coliand Gram-positive cocci were diagnosed by general diagnostic bacteriological methods. Disc diffusion method used for antibiotic sensitivity test; two discs were tested, nitrofurination 300 μg and ceftazidime 30 μg. All the statistical analyses were done using SPSS 26 software and the Excel app.RESULTS:From the total of 100-positive specimens, the female was high prevalence with 72 specimens (72%), whereas males were just 28 specimens (28%) significantly (P< 0.0001). Nitrofurination was very sensitive inE. coliat 90.6% compared to G+ cocci at 33.3% (P< 0.0001). Ceftazidime showed no differences betweenE. coli28.1% and G+ cocci 27.8% (P= 0.97).CONCLUSION:Nitrofurination is effective in bothE. coliand G+ ve cocci, but it is more effective against Gram-negative bacteria(E. coli)90.6% than G+ ve cocci 33.3% significantly (P< 0.0001). There is no significant correlation between ceftazidime and nitrofurantoin (r= −0.07,P= 0.44).